FDA Determines Regulatory Review Period for Heart Laser System Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the Heart Laser System, a medical device, in accordance with patent extension regulations, following a submission to the US Department of Commerce's Commissioner of Patents and Trademarks.